TMCI

4.46

2.19% -0.10

Vorhandelsmarkt: 4.41 -0.05 -1.12%

Treace Medical Concepts Inc (TMCI)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$4.56

Offen:

$4.5

24-Stunden-Volumen:

271.10K

Relative Volume:

0.39

Marktkapitalisierung:

$290.05M

Einnahmen:

$207.32M

Nettoeinkommen (Verlust:

$-61.04M

KGV:

-4.657

EPS:

-0.9577

Netto-Cashflow:

$-25.97M

1W Leistung:

-1.11%

1M Leistung:

+5.44%

6M Leistung:

+135.98%

1J Leistung:

-37.54%

1-Tages-Spanne:

$4.30

$4.51

1-Wochen-Bereich:

$4.30

$4.79

52-Wochen-Spanne:

$1.17

$7.78

Treace Medical Concepts Inc Stock (TMCI) Company Profile

Firmenname

Treace Medical Concepts Inc

Sektor

Healthcare (1077)

Branche

Medical Devices (140)

Telefon

(904) 373-5940

Adresse

100 PALMETTO PARK PLACE, PONTE VEDRA

Mitarbeiter

450

Twitter

Nächster Verdiensttermin

2026-08-07

Neueste SEC-Einreichungen

TMCI's Discussions on Twitter

Compare TMCI vs ABT, SYK, MDT, BSX, EW

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TMCI Treace Medical Concepts Inc	4.46	296.56M	207.32M	-61.04M	-25.97M	-0.9577
ABT Abbott Laboratories	114.14	198.01B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	327.70	130.41B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	92.30	120.48B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	49.37	75.37B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.83	53.19B	6.30B	1.07B	1.09B	1.8406

Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-11-07	Herabstufung	BTIG Research	Buy → Neutral
2025-11-07	Herabstufung	JP Morgan	Neutral → Underweight
2025-02-04	Hochstufung	BTIG Research	Neutral → Buy
2024-12-31	Eingeleitet	Lake Street	Buy
2024-12-17	Fortgesetzt	JP Morgan	Neutral
2024-05-16	Herabstufung	UBS	Buy → Neutral
2024-05-08	Herabstufung	BTIG Research	Buy → Neutral
2024-05-08	Herabstufung	JP Morgan	Overweight → Neutral
2024-05-08	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-05-08	Herabstufung	Stifel	Buy → Hold
2024-05-08	Herabstufung	Truist	Buy → Hold
2023-09-29	Eingeleitet	UBS	Buy
2023-05-01	Eingeleitet	Truist	Buy
2023-04-11	Eingeleitet	Stephens	Equal-Weight
2022-05-12	Eingeleitet	BTIG Research	Buy
2022-01-07	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2021-05-18	Eingeleitet	JP Morgan	Overweight
2021-05-18	Eingeleitet	Morgan Stanley	Equal-Weight
2021-05-18	Eingeleitet	SVB Leerink	Outperform
2021-05-18	Eingeleitet	Stifel	Buy

Alle ansehen

Treace Medical Concepts Inc Aktie (TMCI) Neueste Nachrichten

Aug 19, 2026

TMCI senior director charged with insider trading in U.S. - Peoples Gazette Nigeria

Aug 19, 2026

Aug 18, 2026

Did You Lose Money on Treace Medical Concepts, Inc. (TMCI)? Levi - The National Law Review

Aug 18, 2026

Treace Medical Concepts Earnings Call Signals Cautious Rebound - TipRanks

Aug 18, 2026

Aug 17, 2026

522,900 Shares in Treace Medical Concepts, Inc. $TMCI Purchased by Renaissance Technologies LLC - MarketBeat

Aug 17, 2026

Aug 15, 2026

TMCI Q2 2026 Earnings: EPS Beat Drives 6.2% Stock Uptick as Losses NarrowProfit Warning Alert - Vinanet

Aug 15, 2026

Aug 14, 2026

Armistice Capital (TMCI) discloses 6.36M-share Treace Medical ownership stake - Stock Titan

Aug 14, 2026

Aug 12, 2026

Treace Medical Concepts (TMCI) officer disposes shares for tax or exercise costs - Stock Titan

Aug 12, 2026

Treace Medical Concepts (TMCI) CEO John T. Treace reports 19.2% beneficial stake - Stock Titan

Aug 12, 2026

Treace Medical Concepts (TMCI) CFO uses 37,102 shares to cover equity-related taxes - Stock Titan

Aug 12, 2026

Treace Medical Concepts (TMCI) officer uses 16,253 shares for tax or exercise costs - Stock Titan

Aug 12, 2026

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.50 - simplywall.st

Aug 12, 2026

Aug 11, 2026

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Reduce" by Analysts - marketbeat.com

Aug 11, 2026

Aug 10, 2026

Treace Medical Concepts (NASDAQ:TMCI) Price Target Raised to $5.00 at Truist Financial - MarketBeat

Aug 10, 2026

Truist Securities Adjusts PT on Treace Medical Concepts to $5 From $4, Keeps Hold Rating - marketscreener.com

Aug 10, 2026

Aug 09, 2026

Treace Medical Concepts (TMCI) Stock Jumps As Cash Burn Eases But Sales Stall - Sahm

Aug 09, 2026

Aug 08, 2026

Treace Medical Concepts: Q2 Earnings Snapshot - theheraldreview.com

Aug 08, 2026

Aug 07, 2026

Treace Medical Concepts (NASDAQ:TMCI) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat

Aug 07, 2026

Form 8K Treace Medical Concepts Inc For: 7 August By Investing.com - Investing.com Nigeria

Aug 07, 2026

Treace Medical Concepts, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Aug 07, 2026